The new scope of condition-specific markers, NGS and genomics with advances in molecular diagnostics caters to need of rapid diagnostics, early detection and point-of-care testing. Various technological developments and advancements in in vitro diagnostics have led to a new variety of diagnostic tests, allowing patients to access novel treatments earlier.

After the success of inaugural congress held on 9th and 10th November 2016, MarketsandMarkets is organizing Infectious Diseases Diagnostics Conference to be held on February 21st  and 22nd , 2018 in London, UK, aims to bring different stakeholders together from hospitals, laboratories academic institutes and IVD industry leaders to discuss about the emerging technologies and potential growth of molecular diagnostics and challenges faced in point-of-care testing and antimicrobial resistance. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced.

20% discount on registration for United Life Sciences and OBNmembers.

Find out more here